martes, 6 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Via News Knowledge File

Micron Technology Inc

organization80% conf.·synced Oct 6, 2026

Memory and storage solutions manufacturer

60
sourced metrics
897
relationships
20
stated objectives
7
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
1063.96USD
Oct 5, 2026reference only
Market Cap
1201629136938USD
Oct 5, 2026reference only
Price 52 Week Low
181.60USD
Oct 5, 2026reference only
Stock Return Ytd
237.3%
Oct 5, 2026reference only
Price 52 Week High
1213.56USD
Oct 5, 2026reference only
Shares Outstanding
1129393151.0shares
Jun 17, 2026reference only
Cash
24995000000.0USD
May 28, 2026reference only
Cost Of Revenue
6400000000.0USD
May 28, 2026reference only
Stockholders Equity
100724000000.0USD
May 28, 2026reference only
Revenue
41456000000.0USD
May 28, 2026reference only
Net Income
28243000000.0USD
May 28, 2026reference only
Gross Profit
35056000000.0USD
May 28, 2026reference only
Total Liabilities
33388000000.0USD
May 28, 2026reference only
Operating Income
33318000000.0USD
May 28, 2026reference only
Total Assets
134112000000.0USD
May 28, 2026reference only
Rd Expense
1316000000.0USD
May 28, 2026reference only
Eps
24.67USD_per_share
May 28, 2026reference only
Capex
5389000000.0USD
Nov 27, 2025reference only

Stated objectives

Achieve adjusted EPS of around $19.15 in Q3

source
target: 19.15 USD per share stated

Grow HBM market to $100 billion total addressable market

source
target: 100 billion USD by 2028-01-01 00:00:00stated

Begin production at Singapore HBM fab

source
by 2027-01-01 00:00:00stated

Begin DRAM production at retooled PSMC Taiwan fab

source
stated

Reach full production at Onondaga County, New York DRAM megafab complex

source
by 2030-01-01 00:00:00stated

Micron guided to Q1 FY2025 revenue between $12.2bn and $12.8bn

source
target: 12.2–12.8 billion USD stated

Micron guided to Q1 FY2025 adjusted EPS between $3.60 and $3.90

source
target: 3.60–3.90 USD EPS stated

$20 billion capital investment for fiscal 2026 including New York megafab and Idaho facility

source
target: 20 billion USD stated

Strategic focus on high-growth data center segments following exit from consumer products

source
stated

Complete first semiconductor fabrication facility outside Syracuse

source
by 2030-12-31 00:00:00stated

Relationship graph · 897 connections

Competes with
208
Supplies to
181
Covered by
162
Developed by
83
Invested in
50
Customer of
43
located in
31
Employs
30
has patent dispute with
Netlist

Via News coverage

El auge de la infraestructura de IA, medido en las cuentas de Micron: el gasto en inversión se duplicó en dos años mientras el consumo y la tecnología especulativa flaquean
October 1, 2026
La fiebre inversora de los chips de IA: lo que un inversor en España o Latinoamérica puede verificar antes de comprar
September 28, 2026
El auge de los chips de IA financiariza el sector: Nvidia propone titulizar GPU por 500.000 millones mientras Micron dispara su inversión
September 4, 2026
Nvidia propone titulizar chips por 500.000 millones de dólares mientras Washington financia a GlobalFoundries: el boom de la IA obliga a reinventar cómo se paga el hardware
September 1, 2026
Cuando el chip se convierte en bono: la fiebre de la IA reescribe cómo se financian los semiconductores
August 22, 2026
El superciclo de los chips de IA sigue firmando acuerdos multimillonarios mientras Wall Street castiga al sector con una corrección del 25%
August 16, 2026
La fiebre de los chips de IA se enfría en Wall Street: qué significa para los inversores hispanohablantes cuando ni un solo protagonista del expediente es de habla hispana
August 15, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com